HC Wainwright Reiterates Buy Rating for Applied DNA Sciences

Applied DNA Sciences (NASDAQ:APDN – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a report issued on Thursday, Benzinga reports. They presently have a $4.00 price objective on the technology company’s stock. HC Wainwright’s target price would indicate a potential upside of 187.77% from the stock’s […]

Related Keywords

, Raymond James Associates , Sciences Stock Performance , Sciences Daily , Mdx Testing Services , Sciences Inc , Production Services , Virtu Financial , Sciences Company Profile , Prudential Financial Inc , Atria Wealth Solutions Inc , Get Free Report , Street Corp , Atria Wealth Solutions , Testing Services , Security Products , Applied Dna Sciences , Nasdaq Apdn , Apdn , Industrial Product , Reiterated Rating , Hc Wainwright ,